Cordula Petersen
Papers
2
Total Citations
206
H-Index
2
About
Cordula Petersen is a leading German radiation oncologist whose research centers on stereotactic body radiotherapy (SBRT) for oligometastatic disease and early-stage lung cancer. Her major contributions include pioneering the DEGRO SBRT database initiative, which systematically analyzed patterns of care and outcomes for liver oligometastases. Her landmark 2018 study, with 152 citations, evaluated 474 patients and 623 liver metastases, establishing critical factors influencing local control and overall survival after SBRT. Additionally, her 2017 planning benchmark study for early-stage NSCLC (54 citations) set quality standards for SBRT delivery. Dr. Petersen's work has been instrumental in defining evidence-based SBRT protocols, demonstrating that precise, high-dose radiation can achieve durable tumor control with minimal toxicity. Her research directly impacts clinical decision-making for patients with limited metastatic spread, offering a non-invasive alternative to surgery. As a key figure in the German Society for Radiation Oncology (DEGRO), she continues to shape national treatment guidelines and foster multicenter collaboration, advancing the role of SBRT in modern oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Planning benchmark study for SBRT of early stage NSCLC54 citations · 2017